首页 | 本学科首页   官方微博 | 高级检索  
检索        


Deep Phenotyping and Prediction of Long-term Cardiovascular Disease: Optimized by Machine Learning
Institution:1. Cardiology Department, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China;2. NHC Key Laboratory of Assisted Circulation (Sun Yat-sen University), Guangzhou, China;3. Department of Statistical Science, School of Mathematics, Southern China Center for Statistical Science, Sun Yat-sen University, Guangzhou, China;4. Department of Health, Guangdong Pharmaceutical University, Guangzhou Higher Education Mega Center, Guangzhou, China;5. Department of Statistical Science, School of Mathematics, Sun Yat-sen University, Guangzhou, China;6. Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China;7. Xinhua College, Sun Yat-sen University, Guangzhou, China;1. Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Ontario, Canada;2. Division of Cardiology, Department of Medicine, Memorial University, St. John''s, Newfoundland, Canada;3. Division of Cardiovascular Surgery, Peter Munk Cardiac Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada;4. Division of Cardiac Anesthesiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada;5. Department of Surgery, New Brunswick Heart Center, Saint John, New Brunswick, Canada;6. Faculté de pharmacie, Université Laval, Institut universitaire de cardiologie et de pneumologie de Québec, Québec City, Québec, Canada;7. Département de Chirurgie, Université Laval, Institut universitaire de cardiologie et de pneumologie de Québec, Québec City, Québec, Canada;8. Peter Munk Cardiac Centre and Heart and Stroke Richard Lewar Centre, University of Toronto, Toronto, Ontario, Canada;9. Division of Cardiac Surgery, QEII Health Sciences Centre, Halifax, Nova Scotia, Canada;10. Department of Cardiovascular Surgery, Maine Medical Center, Portland, Maine, USA;11. Division of Cardiac Surgery, St. Mary’s General Hospital, Kitchener, Ontario, Canada;12. Keenan Research Centre for Biomedical Science, UnityHealth, University of Toronto, Toronto, Ontario, Canada;13. Department of Cardiac Sciences, Section of Cardiac Surgery, Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada;14. Department of Medicine, New Brunswick Heart Center, Saint John, New Brunswick, Canada;15. Department of Surgery, McMaster University, Hamilton, Ontario, Canada;p. Department of Medicine and Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada;q. Department of Surgery, Section of Cardiac Surgery, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada;1. Division of Cardiac Surgery, St Michael''s Hospital, University of Toronto, Toronto, Ontario, Canada;2. Department of Otolaryngology-Head & Neck Surgery, Health Sciences Centre, University of Manitoba, Manitoba, Winnipeg, Canada;3. Division of Cardiac Surgery, Royal Jubilee Hospital, Victoria, British Columbia, Canada;4. Division of Cardiac Surgery, New Brunswick Heart Centre, Saint John, New Brunswick, Canada;5. Division of Cardiac Surgery, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada;6. Division of Cardiovascular Surgery, St. Mary’s General Hospital, Kitchener, Ontario, Canada;7. Department of Surgery, Section of Cardiac Surgery, Max Rady College of Medicine, University of Manitoba, Manitoba, Winnipeg, Canada;1. Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA;2. Humanitas Research Hospital IRCCS, Rozzano, Milan, Italy;3. Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA;4. Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy;5. Albany Medical College, Albany, New York, USA;6. Department of Cardiology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA;1. O’Brien Institute of Public Health, University of Calgary, Calgary, Alberta, Canada;2. Department of Cardiac Sciences, Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada;3. Health Technology Assessment and Innovation Department, Alberta Health Services, Edmonton, Alberta, Canada;4. AHS Data Analytics, Alberta Health Services, Edmonton, Alberta, Canada;5. Alberta Health Services, Red Deer Regional Hospital, Red Deer, Alberta, Canada;6. Alberta Health Services, Chinook Regional Hospital, Lethbridge, Alberta, Canada;7. Alberta Health Services, Foothills Medical Centre, Calgary, Alberta, Canada;1. Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada;2. Canadian Women’s Heart Health Centre, University of Ottawa Heart Institute, Ottawa, Ontario, Canada;3. Division of Cardiac Prevention and Rehabilitation, University of Ottawa Heart Institute, Ottawa, Ontario, Canada
Abstract:BackgroundPrediction of cardiovascular disease (CVD) is important in clinical practice. Machine learning (ML) may offer an improved alternative to current CVD risk stratification in individual patients. We aim to identify important predictors and compare ML models with traditional models according to their prediction performance in a large long-term follow-up cohort.MethodsThe Atherosclerosis Risk in Communities (ARIC) study was designed to study the progression of subclinical disease to cardiovascular events over a 25-year follow-up period. All phenotypic variables at visit 1 were obtained. All-cause death, CVD, and coronary heart disease were the outcomes for analysis. The ML framework involved variable selection using the random survival forest (RSF) method, model building, and 5-fold cross-validation. Model performance was evaluated by discrimination using the Harrell concordance index (C-index), accuracy using the Brier score (BS), and interpretability using the number of variables in the model.ResultsOf the 14,842 participants in ARIC, the average age was 54.2 years, with 45.2% male and 26.2% Black participants. Thirty-eight unique variables were selected in the RSF top 20 importance ranking of all 6 outcomes. Aging, hypertension, glucose metabolism, renal function, coagulation, adiposity, and sodium retention dominated the predictions of all outcomes. The ML models outperformed the regression models and established risk scores with a higher C-index, lower BS, and varied interpretability.ConclusionsThe ML framework is useful for identifying important predictors of CVD and for developing models with robust performance compared with existing risk models.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号